HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Article Information
vol. 41 no. 9 1981-1990
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 21, 2018
- Accepted May 17, 2018
- Published in print August 22, 2018.
- Published online ahead of print June 24, 2018.
Article Versions
- Previous version (June 24, 2018 - 14:06).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Thomas Danne1⇑,
- Bertrand Cariou2,
- Phillip Banks3,
- Michael Brandle4,
- Helmut Brath5,
- Edward Franek6,
- Jake A. Kushner7,
- Pablo Lapuerta3,
- Darren K. McGuire8,
- Anne L. Peters9,
- Sangeeta Sawhney3 and
- Paul Strumph3
- 1Department of Diabetes, Endocrinology, and Clinical Research, Children’s and Youth Hospital Auf der Bult, Hannover Medical School, Hannover, Germany
- 2L’institut du thorax, Department of Endocrinology, CHU Nantes, CIC 1413, INSERM, Nantes, France
- 3Lexicon Pharmaceuticals, Inc., The Woodlands, TX
- 4Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland
- 5Diabetes Outpatient Clinic, Health Center South, Vienna, Austria
- 6Mossakowski Medical Research Center, Polish Academy of Sciences, Warsaw, Poland
- 7Department of Pediatrics, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX
- 8Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX
- 9University of Southern California Keck School of Medicine, Los Angeles, CA
- Corresponding author: Thomas Danne, danne{at}hka.de.
Statistics from Altmetric.com
Article usage
In this Issue
September 2018, 41(9)
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
